Alnylam Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.About ALNY
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference.
ALNY Key Statistics
Stock Snapshot
As of today, Alnylam Pharmaceuticals(ALNY) shares are valued at $460.54. The company's market cap stands at 60.85B, with a P/E ratio of 1868.39.
As of 2025-11-17, Alnylam Pharmaceuticals(ALNY) stock has fluctuated between $449.00 and $463.75. The current price stands at $460.54, placing the stock +2.6% above today's low and -0.7% off the high.
The Alnylam Pharmaceuticals(ALNY)'s current trading volume is 961.56K, compared to an average daily volume of 905.59K.
In the last year, Alnylam Pharmaceuticals(ALNY) shares hit a 52-week high of $495.55 and a 52-week low of $205.87.
In the last year, Alnylam Pharmaceuticals(ALNY) shares hit a 52-week high of $495.55 and a 52-week low of $205.87.
ALNY News
Below is Validea's guru fundamental report for ALNYLAM PHARMACEUTICALS, INC. (ALNY). Of the 22 guru strategies we follow, ALNY rates highest using our Twin Mome...
Earlier this week, Alnylam Pharmaceuticals announced and presented new post hoc analyses from the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), revealing am...
Wells Fargo analyst Tiago Fauth raised the firm’s price target on Alnylam (ALNY) to $479 from $395 and keeps an Equal Weight rating on the shares. The firm beli...
Analyst ratings
71%
of 31 ratingsMore ALNY News
No investment is a slam dunk to double your money. But these great stocks appear to have what it takes. Some stocks are similar to the tortoise in Aesop's famo...
